TWIST BIOSCIENCE CORP (TWST:NASDAQ)
$90.09 4.62 (5.4054%)
Analysed TWIST BIOSCIENCE CORP (TWST:NASDAQ) News Sources
Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?
14-07-2026
fool.com
Cathie Wood’s ARK Invest Doubles Down On Circle In Two Funds At Once, Trims Robinhood Again
15-07-2026
stocktwits.com
Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026
15-07-2026
yahoo.com
Cathie Wood Is Selling This High-Flying Stock. Is It a Buy?
19-07-2026
fool.com
Cathie Wood Dumps $39 Million Worth of AMD Stock
20-07-2026
yahoo.com
Twist Bioscience (TWST) Surged on Strong Results and AI Drug Discovery Demand
24-07-2026
yahoo.com
Twist Bioscience (TWST) Stock Looks Overvalued Even With Strong Growth Hopes
26-07-2026
yahoo.com
Leerink Partners Report Names Carterra a Core Enabler of the $7B "Lab-in-the-Loop" Antibody Discovery Market
27-07-2026
yahoo.com
Alpha Cognition Inc. (ACOG) Surges 8.6%: Is This an Indication of Further Gains?
28-07-2026
yahoo.com
Kiniksa Pharmaceuticals International, plc (KNSA) Q2 Earnings Match Estimates
28-07-2026
yahoo.com
What is the current price of TWIST BIOSCIENCE CORP (TWST:NASDAQ)?
The current price of TWIST BIOSCIENCE CORP (TWST:NASDAQ) is $90.09.
TWIST BIOSCIENCE CORP (TWST:NASDAQ) absolute price change since previous trading day?
The absolute price change of TWIST BIOSCIENCE CORP (TWST:NASDAQ) since the previous trading day is $4.62.
TWIST BIOSCIENCE CORP (TWST:NASDAQ) percentage price change since previous trading day?
The percentage price change of TWIST BIOSCIENCE CORP (TWST:NASDAQ) since the previous trading day is 5.4054%.
What is the most recent average sentiment score for TWIST BIOSCIENCE CORP (TWST:NASDAQ)?
The most recent average sentiment score for TWIST BIOSCIENCE CORP (TWST:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for TWIST BIOSCIENCE CORP (TWST:NASDAQ)?
The most recent sentiment for TWIST BIOSCIENCE CORP (TWST:NASDAQ) is .
SEC-8K** Filing Available For TWIST BIOSCIENCE CORP (TWST:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.